Verticillium albo-atrum
Verticillium albo-atrum is a soil-borne fungus that is known to cause Verticillium wilt, a serious disease in a wide range of plants. This fungus is a member of the Verticillium genus, which includes other plant pathogens such as Verticillium dahliae and Verticillium longisporum.
Taxonomy[edit]
Verticillium albo-atrum belongs to the Fungal kingdom, specifically within the Ascomycota phylum. It is part of the Hypocreales order and the Nectriaceae family. The genus Verticillium contains around 10 species, with V. albo-atrum being one of the most well-known due to its impact on agriculture.
Morphology[edit]
Verticillium albo-atrum is characterized by its hyphae, which are highly branched and septate. The fungus produces conidia in chains, which are borne on conidiophores that arise from the hyphae. The conidia are hyaline, single-celled, and elliptical in shape.
Pathogenicity[edit]
Verticillium albo-atrum is a hemibiotroph, meaning it spends part of its life cycle as a biotroph, living in the host plant without killing it, and part as a necrotroph, killing and then living off the dead tissue. The fungus enters the plant through the roots and colonizes the xylem, causing wilting and death of the plant.
Control[edit]
Control of Verticillium albo-atrum is challenging due to its ability to survive in the soil for many years as microsclerotia. Strategies for control include the use of resistant cultivars, crop rotation, and soil fumigation. However, these methods are not always effective, and research is ongoing to develop more effective control strategies.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
